Male hormonal contraception: looking back and moving forward

about

Male Hormonal Contraception: Where Are We Now?Are men ready to use thermal male contraception? Acceptability in two French populations: New fathers and new providers.The future of male contraception: a fertile ground.

P2860

Q26767429-EE65C242-861E-4ECB-A1FE-68F257A5202C Q55307949-A7D6EF18-AB9F-417C-8B02-174C9EDFD924 Q55389411-9C1F5930-84AE-43E9-98F4-CCD490A38952

P2860

Male hormonal contraception: looking back and moving forward

Item

http://www.wikidata.org/entity/Q36479889

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Male hormonal contraception: looking back and moving forward

@ast

Male hormonal contraception: looking back and moving forward

@en

type

Item

label

Male hormonal contraception: looking back and moving forward

@ast

Male hormonal contraception: looking back and moving forward

@en

prefLabel

Male hormonal contraception: looking back and moving forward

@ast

Male hormonal contraception: looking back and moving forward

@en

P1476

Male hormonal contraception: looking back and moving forward

@en

P2093

M Y Roth

http://www.w3.org/2001/XMLSchema#string

S T Page

http://www.w3.org/2001/XMLSchema#string

W J Bremner

http://www.w3.org/2001/XMLSchema#string

P2860

Contraceptive failure in the United States

Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men

Spermiation: The process of sperm release

Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility

Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men

A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations

Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole

Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.

Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth.

Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.

P304

4-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANDR.12110

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26453296

http://www.w3.org/2001/XMLSchema#string

P921

contraception

P932

4718868

http://www.w3.org/2001/XMLSchema#string

Male hormonal contraception: looking back and moving forward

about

P2860

P2860

Male hormonal contraception: looking back and moving forward

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932